P. Bardin

Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

L. Touqui, C. Mitri, Zheng-zhong Xu, 2020, Frontiers in Pharmacology.

miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis

N. Rousselet, P. Bardin, H. Corvol, 2019, Front. Immunol..

Single-cell RNA sequencing-based characterization of resident lung mesenchymal stromal cells in bronchopulmonary dysplasia

B. Vanderhyden, O. Carpén, B. Thébaud, 2021, bioRxiv.

Small RNA and transcriptome sequencing reveal the role of miR‐199a‐3p in inflammatory processes in cystic fibrosis airways

N. Rousselet, P. Bardin, H. Corvol, 2018, The Journal of pathology.

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis

P. Bardin, H. Corvol, O. Tabary, 2018, Front. Pharmacol..

Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.

P. Bardin, P. Bardin, J. Moolman, 1991, Thorax.